Clinical Trial Update: PDMC Implementation Trial in Kenya [Phase 4]

View source ↗

Summary

Phase 4 clinical trial in Kenya evaluating the real-world implementation of post-discharge malaria chemoprevention for children hospitalized with severe malaria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Malaria

Drugs mentioned

• Dihydroartemisinin-piperaquine (dihydroartemisinin-piperaquine)

Snippet

Sponsor: Liverpool School of Tropical Medicine | Conditions: Severe Malaria, Severe Anemia | Phase 4 | Status: RECRUITING